Health and Fitness Health and Fitness
Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Media Advisory - Oncolytics Biotech(R) Inc. to Present at JMP Securities Healthcare Conference
[ Mon, Sep 27th 2010 ] - Market Wire
GenMark Diagnostics Selected as Diagnostic Platform in Warfarin Clinical Trial
[ Mon, Sep 27th 2010 ] - Market Wire
Rotech Healthcare Inc. Announces Proposed Private Offering of $225 Million Senior Secured Notes
[ Mon, Sep 27th 2010 ] - Market Wire
Seattle Genetics and Millennium Announce Positive .. (SGN-35) Data from Pivotal Trial in Relapsed and
[ Mon, Sep 27th 2010 ] - Market Wire
Wellstar Announces New Website
Sun, September 26, 2010
[ Sun, Sep 26th 2010 ] - Market Wire
Aetna ©largit le spectre des Options de son Plan de sant© en Afrique
[ Sun, Sep 26th 2010 ] - Market Wire
Aetna Expands Africa Health Plan Options
Sat, September 25, 2010
[ Sat, Sep 25th 2010 ] - Market Wire
ANGIOTECH ANNOUNCES THREE YEAR DATA FROM THE HORI .. IOR OUTCOMES WITH BOSTON SCIENTIFIC CORPORATION'S
Fri, September 24, 2010
[ Fri, Sep 24th 2010 ] - Market Wire
Harwood Feffer LLP Files Class Action On Behalf O .. c. Securities For The Enlarged Class Period March
[ Fri, Sep 24th 2010 ] - Market Wire
Novartis AG, Merck KGaA, Biogen Idec, Teva and Bed Bath & Beyond
[ Fri, Sep 24th 2010 ] - Market Wire
Allergan Receives FDA Approval for OZURDEX® as T .. ious Uveitis Affecting the Posterior Segment of t
[ Fri, Sep 24th 2010 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. arding Top-line Data from Brentuximab Vedotin (SG
[ Fri, Sep 24th 2010 ] - Market Wire
CIGNA Corporation Announces Investor Day on March 11, 2011
[ Fri, Sep 24th 2010 ] - Market Wire
Aetna Board of DirectorsDeclares Annual Cash Dividend
[ Fri, Sep 24th 2010 ] - Market Wire
Health Net Sponsors the 7th Annual Navy 5 Miler
[ Fri, Sep 24th 2010 ] - Market Wire
Amedisys to Present at JMP Securities Healthcare Conference
[ Fri, Sep 24th 2010 ] - Market Wire
SEMBIOSYS ANNOUNCES IT IS PURSUING STRATEGIC ALTERNATIVES
[ Fri, Sep 24th 2010 ] - Market Wire
Clinical Data, Inc. Presents Data from Phase I St .. ating Safety and Tolerability in Patients with As
[ Fri, Sep 24th 2010 ] - Market Wire
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
[ Fri, Sep 24th 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Exercise of Unde .. Additional Convertible Senior Subordinated Notes
[ Fri, Sep 24th 2010 ] - Market Wire
Celgene Corporation to Present at the JMP Securities Fifth Annual Healthcare Conference
[ Fri, Sep 24th 2010 ] - Market Wire
52-Week Phase 3 Study Found Investigational Drug .. Similar to Glipizide Plus Metformin in Improving
Thu, September 23, 2010
[ Thu, Sep 23rd 2010 ] - Market Wire
Minist©rio da Sade do Brasil concede Zoll AED co .. do Sistema Pblico de Servios de Emergncia M©dica
[ Thu, Sep 23rd 2010 ] - Market Wire
LecTec Corporation Announces Results of 2010 Shareholders Meeting
[ Thu, Sep 23rd 2010 ] - Market Wire
Brazil Ministry of Health Awards Zoll AED Contract for Public EMS System
[ Thu, Sep 23rd 2010 ] - Market Wire
Alnylam Provides Update on Novartis Collaboration .. turing, and Reaffirms Financial Guidance for 2010
[ Thu, Sep 23rd 2010 ] - Market Wire
Kindred Healthcare Announces Amendment to Credit .. nt to Increase Available Acquisition Capabilities
[ Thu, Sep 23rd 2010 ] - Market Wire
American CareSource To Present at the JMP Securities Healthcare Conference
[ Thu, Sep 23rd 2010 ] - Market Wire
PPD Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call
[ Thu, Sep 23rd 2010 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. sentation at JMP Securities Healthcare Conference

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Healthcare Conference


Published on 2010-09-23 13:10:42 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the Fifth Annual JMP Securities Healthcare Conference will be webcast and may be accessed at [ www.hgsi.com ].

A member of Human Genome Sciencesa™ senior management team will present a corporate overview on Monday, September 27, 2010, at 11:30 AM Eastern. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

For more information about HGS, please visit the Companya™s web site at [ www.hgsi.com ]. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to [ medinfo@hgsi.com ] or by calling HGS at (877) 822-8472.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.

Contributing Sources